−2.76 M EUR
0.00 EUR
About AMNIOTICS AB
Sector
Industry
CEO
Marcus Kåre Torleif Larsson
Website
Headquarters
Lund
Founded
2015
ISIN
SE0015961016
FIGI
BBG011N363Z3
Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term amniotic fluid. Based on a decade of research at the internationally recognized Lund University Stem Cell Centre and the University Hospital of Lund, the company is pioneering the harvesting and propagation of tissue specific neonatal quality mesenchymal stem cells (MSC). These stem cells have unique properties for applications in regenerative medicine. Amniotics has also an, by Läkemedelsverket (MPA in Sweden), approved GMP (Good Manufacturing Practice) manufacturing facility to produce Advanced therapy medicinal products (ATMPs). With the GMP facilities operational since 2020, Amniotics is now moving into clinical trials with the leading drug candidate, PulmoStem™ and is looking to establish strategic partnerships with researchers and companies that are interested in developing stem-cell-based therapies targeting diseases with high unmet needs.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 66J is 0.00 EUR — it has increased by 50.00% in the past 24 hours. Watch AMNIOTICS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange AMNIOTICS AB stocks are traded under the ticker 66J.
66J stock is 100.00% volatile and has beta coefficient of −2.35. Track AMNIOTICS AB stock price on the chart and check out the list of the most volatile stocks — is AMNIOTICS AB there?
Yes, you can track AMNIOTICS AB financials in yearly and quarterly reports right on TradingView.
No, 66J doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 3, 2025, the company has 6.00 employees. See our rating of the largest employees — is AMNIOTICS AB on this list?
Like other stocks, 66J shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMNIOTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMNIOTICS AB technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMNIOTICS AB stock shows the neutral signal. See more of AMNIOTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.